You are viewing: Australia Pulse Oximeter Market analysis
Part of: Pulse Oximeter Market (Global)

The Australia Pulse Oximeter Market was valued at $122.9 Million in 2025 and projected to reach to $216.7 Million by 2030, representing a compound annual growth rate of 8.4%. Australia's pulse oximeter market is positioned for sustained growth through 2030, driven by demographic pressures from an aging population and increasing healthcare system demands.

Australia Pulse Oximeter Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Pulse Oximeter Market Trends and Insights

  • This expansion reflects Australia's aging population, rising prevalence of chronic respiratory and cardiovascular diseases, and increasing adoption of remote patient monitoring technologies across healthcare facilities.
  • Australia's strong healthcare infrastructure and government support for digital health initiatives are driving demand for non-invasive monitoring devices. The Australian pulse oximeter market benefits from high healthcare spending, widespread availability of advanced medical devices, and growing consumer awareness of preventive health monitoring.
  • Australia's regulatory environment and emphasis on quality standards ensure that only certified, reliable devices enter the market.
  • Between 2025 and 2030, Australia is expected to see accelerated adoption in both hospital and home-care settings, supported by telehealth expansion and integration with wearable health technologies..

Key Market Statistics

  • CAGR (2025-2030) 8.4% CAGR
  • Market Size, 2025 ~USD 122.9 Million
  • Forecast, 2030 ~USD 216.7 Million
  • Country Australia

Australia Pulse Oximeter Market Overview

Market Valuation Growth :

Australia's pulse oximeter market is valued at USD 122.9 million in 2025, with a projected CAGR of 8.4% through 2030, reaching USD 216.7 million by forecast end.

Aging Population Driver :

Australia's demographic shift toward an older population is significantly increasing demand for pulse oximetry devices, particularly in aged care facilities and home healthcare settings.

Remote Patient Monitoring Adoption :

Healthcare facilities across Australia are rapidly adopting remote patient monitoring technologies, with pulse oximeters becoming essential tools for continuous health surveillance and telehealth initiatives.

Chronic Disease Prevalence :

Rising prevalence of respiratory and cardiovascular diseases in Australia is driving clinical demand for reliable pulse oximetry solutions across hospitals, clinics, and primary care centers.

Australia Pulse Oximeter Market Dynamics

  • The integration of remote patient monitoring into Australia's healthcare infrastructure is accelerating adoption rates, particularly in rural and regional areas where telehealth solutions address accessibility challenges.
  • Healthcare providers are investing in advanced pulse oximetry technologies to improve patient outcomes and reduce hospital readmissions.
  • Government initiatives supporting digital health and chronic disease management further strengthen market expansion prospects.
  • The competitive landscape is intensifying as both established medical device manufacturers and innovative startups target the Australian healthcare sector with next-generation solutions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Australia's pulse oximeter market is valued at USD 122.9 million in 2025 and will grow to USD 216.7 million by 2030, representing a compound annual growth rate of 8.4%.
    • Australia's aging demographic and rising chronic disease burden are primary drivers of pulse oximeter adoption across hospitals, clinics, and home-care environments.
    • Government-backed digital health initiatives and telehealth expansion in Australia are accelerating demand for remote monitoring devices including pulse oximeters.
    • Australia's stringent regulatory standards and high healthcare spending create a premium market for advanced, connected pulse oximeter solutions with integrated data analytics.

    Pulse Oximeter Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONNECTED PULSE OXIMETERS (Technology)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.7% from 2025 to 2030
    Largest Segment ADULTS (Age Group)
    Market Size Base Year (Billions) ~USD 3.92 (2025)
    Revenue Forecast (Billions) ~USD 5.95 (2030)
    Segments Covered Product, Type, Technology, Age Group, End User

    Australia Pulse Oximeter Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product

    • Equipment
    • Sensors

    By Type

    • Bedside/Tabletop Pulse Oximeters
    • Disposable Sensors
    • Fingertip Pulse Oximeters
    • Handheld Pulse Oximeters
    • Infants
    • Neonatal
    • Otc Home Use
    • Portable Pulse Oximeters
    • Prescription Home Use
    • Reusable Sensors
    • Wearable Pulse Oximeters

    By Technology

    • Connected Pulse Oximeters
    • Conventional Pulse Oximeters

    By Age Group

    • Adult
    • Adults
    • Pediatric

    By End User

    • Ambulatory Care Centers
    • Ambulatory Care Settings
    • Home Care Settings
    • Hospitals
    • Other End User
    • Other End Users
    • Primary Centers
    • Urgent Care Centers

    AUSTRALIA: PULSE OXIMETER MARKET, BY END USER, 2023–2032

    Segment2023202420252029203020312032CAGR (%)
    AMBULATORY CARE CENTERS9.39.710.413.814.815.8177.2
    HOME CARE SETTINGS26.327.830.241.845.248.952.98.3
    HOSPITALS56.960.465.992.4100.3108.9118.98.8
    OTHER END USERS5.666.59.19.910.711.78.7
    PRIMARY CENTERS3.13.23.54.44.755.36.4
    URGENT CARE CENTERS5.55.86.48.79.510.2118.2
    TOTAL106.8113122.9170.3184.4199.6216.78.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Australia-specific market data to assess market entry opportunities, competitive positioning, and revenue potential in this growing healthcare segment with distinct regulatory and procurement requirements.
    • Healthcare Facility Administrators : Hospital and clinic leaders require market insights to justify capital investments in pulse oximetry infrastructure, benchmark adoption rates against peers, and plan remote monitoring program implementations.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Australia need detailed market sizing, growth projections, and sector dynamics to assess portfolio companies and identify acquisition targets in the pulse oximetry space.
    • Healthcare Consultants & Advisors : Consulting professionals advising Australian healthcare organizations require country-specific market data to develop strategic recommendations, validate business cases, and support digital health transformation initiatives.
    • Government & Policy Makers : Australian health department officials and policy advisors need market intelligence to inform healthcare technology procurement decisions, digital health strategy development, and aged care service planning initiatives.

    Key Companies in the Australia Pulse Oximeter Market

    CompanyHQOwnershipStrongest segments
    MEDTRONICIrelandPublic CompanyEquipment (Bedside and multiparameter-integrated),Sensors (Reusable and disposable),Portable – Handheld,
    MASIMOUnited StatesPrivate CompanyEquipment – Bedside Monitors,Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Consumer,
    NIHON KOHDEN CORPORATIONJapanPublic CompanyEquipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld, wearable-capable, transport),Equipment – Fingertip/consumer-style oximeters,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyEquipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld and wearable clinical devices),Equipment – Fingertip/consumer-oriented devices,
    ICU MEDICAL, INC.United StatesPublic CompanyEquipment – Bedside Pulse Oximeters and Multi-parameter Monitors,Sensors – Reusable and Disposable Oximetry Sensors,Portable – Handheld and Clinical Wearable Oximeters,
    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.ChinaPublic CompanyEquipment – Bedside / Multiparameter Monitors,Equipment – Portable Handheld,Wearable Pulse Oximeters,
    GE HEALTHCAREUnited StatesPublic CompanyEquipment – Bedside and multi-parameter monitors with integrated SpO2,Sensors and disposables,Portable – Handheld and transport oximeters,
    CONTEC MEDICAL SYSTEMS CO., LTD.ChinaPublic CompanyPortable – Fingertip,Portable – Handheld,Portable – Wearable,
    DRäGERWERK AG & CO. KGAAGermanyPublic CompanyEquipment – Bedside Monitors (Conventional & Connected),Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Basic Portable,
    OSI SYSTEMS, INC.United StatesPublic CompanyEquipment – Bedside Monitors,Equipment – Portable (Handheld/Wearable),Sensors and Disposables,
    A&D COMPANY, LIMITEDJapanPublic CompanyEquipment – Portable Handheld,Equipment – Portable Wearable,Equipment – Portable Fingertip,

    MEDTRONIC

    Medtronic is a publicly traded medical device company founded in 1949 and headquartered in Ireland, employing approximately 95,000 people globally.

    MASIMO

    Masimo is a private medical technology company established in 1989 in the United States with 2,200 employees specializing in patient monitoring solutions.

    NIHON KOHDEN CORPORATION

    Nihon Kohden Corporation is a Japanese public company founded in 1951 that employs 6,116 people and operates in the medical device sector.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a large multinational public company founded in 1891 in the Netherlands with 63,670 employees operating across healthcare and technology sectors.

    ICU MEDICAL, INC.

    ICU Medical, Inc. is a publicly traded medical device company founded in 1984 in the United States with 13,000 employees.

    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

    Lepu Medical Technology is a publicly traded Chinese medical device company founded in 1999 in Beijing with 8,689 employees.

    GE HEALTHCARE

    GE Healthcare is a publicly traded healthcare technology company founded in 2022 in the United States with 54,000 employees.

    CONTEC MEDICAL SYSTEMS CO., LTD.

    Contec Medical Systems is a publicly traded Chinese medical device company founded in 1996 with 1,712 employees.

    DRäGERWERK AG & CO. KGAA

    Drägerwerk AG & Co. KGaA is a publicly traded German medical and safety technology company founded in 1889 with 16,033 employees.

    OSI SYSTEMS, INC.

    OSI Systems, Inc. is a publicly traded technology company founded in 1987 in the United States with 7,337 employees.

    A&D COMPANY, LIMITED

    A&D Company, Limited is a large publicly traded Japanese company founded in 1920 with 64,394 employees operating in measurement and medical device sectors.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for Australia's pulse oximeter market with country-specific CAGR analysis, enabling accurate financial forecasting and investment decisions tailored to the Australian healthcare sector.
    • Demographic & Clinical Insights : Understand Australia's unique aging population dynamics and chronic disease prevalence patterns that directly influence pulse oximeter demand, helping identify high-opportunity patient segments and care settings.
    • Technology Adoption Trends : Gain detailed intelligence on remote patient monitoring and telehealth adoption rates specific to Australia, revealing integration opportunities and competitive positioning strategies for healthcare providers and device manufacturers.
    • Regional Market Differentiation : Identify Australia-specific market drivers, regulatory environment, and healthcare infrastructure factors that differentiate this market from global trends, enabling localized go-to-market strategies.
    • Strategic Growth Planning : Leverage Australia-focused market forecasts through 2030 to develop targeted expansion plans, product development roadmaps, and partnership strategies aligned with local healthcare system priorities and investment cycles.

    Frequently asked questions

    What is the current size of the pulse oximeter market in Australia?

    Australia's pulse oximeter market is valued at USD 122.9 million in 2025 and is expected to reach USD 216.7 million by 2030.

    What is the projected growth rate for pulse oximeters in Australia?

    Australia's pulse oximeter market is projected to grow at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

    What factors are driving pulse oximeter demand in Australia?

    Key drivers include Australia's aging population, increasing prevalence of chronic respiratory and cardiovascular diseases, government support for digital health, and growing adoption of remote patient monitoring technologies.

    Which healthcare settings in Australia are adopting pulse oximeters most rapidly?

    Australia is seeing accelerated adoption in both hospital and home-care settings, driven by telehealth expansion and integration with wearable health technologies.

    How does Australia's regulatory environment impact the pulse oximeter market?

    Australia's stringent regulatory standards and emphasis on quality assurance ensure that only certified, reliable devices enter the market, supporting premium-priced advanced solutions.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    This research study used widespread secondary sources; directories, databases such as Dun & Bradstreet, Bloomberg BusinessWeek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pulse oximeters market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply & demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.

    A breakdown of the primary respondents is provided below:

    Pulse Oximeter Market

    Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pulse oximeter market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was made for the major players (who contribute at least 60-70% of the market share at the global level). Also, the global pulse oximeter market was split into various segments and sub-segments based on:

    • List of major players operating in the pulse oximeter devices  market at the regional and/or country level
    • Product mapping of various pulse oximeter device manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from the pulse oximeter segment (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2024
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global pulse oximeter market 
    Pulse Oximeter Market

    Data Triangulation

    After arriving at the market size, the total pulse oximeters market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

    Market Definition

    A pulse oximeter is a non-invasive medical device used to measure the blood's oxygen saturation level (SpO2) and pulse rate. It typically works by emitting light through a body part—usually a fingertip or earlobe—and detecting the amount of oxygenated and deoxygenated hemoglobin based on light absorption.

    Stakeholders

    • Medical device manufacturers
    • Regulatory authorities (e.g., the US FDA and the EMA, among others)
    • Hospitals & clinics
    • Physicians & anesthesiologists
    • Home healthcare providers
    • Distributors & suppliers
    • Research institutes & labs
    • Health insurance companies
    • Government health departments
    • Patients & end-users
    • Medical research institutes
    • Business research & consulting service providers

    Report Objectives

    • To define, describe, segment, and forecast the pulse oximeters market by product, type, age group, technology, end user, and region.
    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pulse oximeter market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the pulse oximeters market in five regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the pulse oximeters market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the pulse oximeters market
    • To benchmark players within the pulse oximeters market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Pulse Oximeter Market Report

    Full forecast, segment splits, and company analysis for all Pulse Oximeter Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status